MA MD MRCOG
- Consultant Gynaecologist and Subspecialist in Reproductive Medicine and Surgery- Oxford University Hospitals NHS Trust
- Medical Director- Oxford Fertility Unit
- Principal Investigator
My undergraduate training was at the Universities of Cambridge and London, followed by postgraduate training in Oxford and Montreal (McGill University). My MD was awarded by the University of London, titled 'Clinical and ultrasound prediction of outcome in unstimulated oocyte in-vitro maturation cycles.'
Following completion of RCOG Sub-Specialist Training in Reproductive Medicine I was appointed in 2004 as a Senior Fellow in the NDOG and an Honorary Consultant Gynaecologist at the John Radcliffe Hospital. I am currently Medical Director of the Oxford Fertility Unit and a Founding Director of The Fertility Partnership, the UK's largest assisted conception network. I was appointed as an Associate Professor in the NDOG in 2015.
I am a member of the Guidelines Development Group for Fertility for NICE (National Institute for Clinical Excellence), on the board of the fertility lobbying group Fertility Fairness, and a member of the Teaching Board for the University of Oxford MSc in Clinical Embryology, which OFU has very close ties with.
My team's research is focussed on elucidating the causes of reproductive failure and examining novel treatment regimes with improved outcomes and reduced risks.
Systematic review of the clinical efficacy of vaginal progesterone for luteal phase support in assisted reproductive technology cycles.
Child T. et al, (2018), Reprod Biomed Online, 36, 630 - 645
Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization.
Mounce G. et al, (2015), Fertil Steril, 104, 915 - 920.e1
BLASTOCYST EXPANSION AND INNER CELL MASS GRADES ARE ASSOCIATED WITH CLINICAL PREGNANCY IN FRESH SINGLE TRANSFERS.
Subira J. et al, (2014), FERTILITY AND STERILITY, 102, E63 - E63
ACCURATE QUANTIFICATION OF SPECIFIC PROTEINS OF INTEREST IN SINGLE HUMAN BLASTOCOELS USING TARGETED MASS SPECTROMETRY.
Poli M. et al, (2014), FERTILITY AND STERILITY, 102, E203 - E203
In vitro maturation and surrogacy in patients with vascular-type Ehlers-Danlos syndrome--a safe assisted reproductive technology approach.
Bergeron M-E. et al, (2014), Hum Fertil (Camb), 17, 141 - 144